Michael Poyurovsky
Tirat Carmel Mental Health Center
9 Eshkol Street
30200
Tirat Carmel
Israel
Name/email consistency: high
- The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study. Poyurovsky, M., Tal, V., Maayan, R., Gil-Ad, I., Fuchs, C., Weizman, A. Eur. Neuropsychopharmacol (2004)
- Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study. Poyurovsky, M., Isaacs, I., Fuchs, C., Schneidman, M., Faragian, S., Weizman, R., Weizman, A. Am. J. Psychiatry (2003)
- Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study. Poyurovsky, M., Koren, D., Gonopolsky, I., Schneidman, M., Fuchs, C., Weizman, A., Weizman, R. Eur. Neuropsychopharmacol (2003)
- Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study. Poyurovsky, M., Epshtein, S., Fuchs, C., Schneidman, M., Weizman, R., Weizman, A. J. Clin. Psychopharmacol (2003)
- Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia. Poyurovsky, M., Kriss, V., Weisman, G., Faragian, S., Kurs, R., Schneidman, M., Fuchs, C., Weizman, A., Weizman, R. J. Clin. Psychiatry (2003)
